$2.75-0.02 (-0.72%)
Rave Restaurant Group, Inc., through its subsidiaries, engages in the operation and franchising of pizza buffet, delivery and carry-out, express restaurants, and ghost kitchens under the Pizza Inn and Pie Five trademarks in the United States and internationally.
Rave Restaurant Group, Inc. in the Consumer Cyclical sector is trading at $2.75. The stock is currently 27% below its 52-week high of $3.75, remaining 6.8% below its 200-day moving average. Technical signals show neutral RSI of 67 and bullish MACD crossover, explaining why RAVE maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Rave Restaurant Group, Inc., through its subsidiaries, engages in the operation and franchising of pizza buffet, delivery and carry-out, express restaurants, and ghost kitchens under the Pizza Inn and Pie Five trademarks in the United States and inte...
Over the last 7 days, the United States market has remained flat, though it has risen 30% in the past year with earnings forecasted to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential can be particularly rewarding. While the term "penny stocks" may seem outdated, it continues to represent smaller or newer companies that offer unique opportunities for investors willing to explore beyond traditional options.
When Uber Eats told its restaurant partners it was raising fees and there was nothing to negotiate, most operators had little choice but to go along. Brandon Solano did not. Solano, CEO of Rave Restaurant Group, the parent company of Pizza Inn and Pie Five, ended his company's partnership with Uber ...
Pizza Inn’s owner said the chain is focusing on dine-in traffic through value offerings instead of increasing volume through unprofitable orders.
Rave Restaurant faces pressure from Pie Five weakness, but Pizza Inn growth, franchise revenue gains and a debt-free balance sheet shape the investment outlook.
Eli Lilly leads top analyst picks as GLP-1 demand, pipeline advances, and global growth momentum drive strong outlook despite rising competition risks.